NEWSNATIONNOW (Adelaide Taylor) - GLP-1s may be misused by patients with eating disorders: Study
According to the study, the prevalence of GLP-1 use is higher among people with eating disorders than the general population.
According to the study, the prevalence of GLP-1 use is higher among people with eating disorders than the general population.
A study of chimps, gorillas and other great apes, including human children, sheds light on how laughter has evolved.
A new study found people who worked remotely often socialized less and were more likely to have higher rates of depression. But those findings contrasted to a different survey that pointed to other struggles for those going into an office. NewsNation’s Kayla Jardine explains.
A study looking at the effectiveness of the COVID-19 vaccine was published after it was blocked from being included in a weekly report from the federal government.
Some patients spend thousands of dollars on these extra ‘add-on’ procedures during fertility treatment.
ABC News' Dr. Darien Sutton talks about what Dr. Anil Menon will be studying during his lengthy spaceflight.
New research suggests GLP-1 drug tirzepatide may increase brown fat activity, helping the body burn more calories beyond reducing appetite.
Mainstream media, former surgeon general hype "nearly 40 percent" reduction in heart problems related to COVID itself, ignoring that it's only 1% of heart problems in study, and Washington Post botches core finding itself.
The oldest known evidence of the plague, which sparked deadly outbreaks dating back about 5,500 years ago is more than 200 years earlier than previously thought.
The study found patients taking Ozempic and Wegovy were noticeably less impulsive and less prone to violence.